Literature DB >> 15075330

Isoform specificity among ankyrins. An amphipathic alpha-helix in the divergent regulatory domain of ankyrin-b interacts with the molecular co-chaperone Hdj1/Hsp40.

Peter J Mohler1, Janis A Hoffman, Jonathan Q Davis, Khadar M Abdi, Chong-Rak Kim, Sarah K Jones, Lydia H Davis, Karen F Roberts, Vann Bennett.   

Abstract

Ankyrins-R, -B, and -G are a family of membrane-associated adaptors required for localization of structurally diverse proteins to specialized membrane domains, including axon initial segments, cardiomyocyte T-tubules, and epithelial cell lateral membranes. Ankyrins are often co-expressed in the same cells and, although structurally similar, have non-overlapping functions. We previously determined that the regulatory domain of ankyrin-B defines specificity between ankyrins B and G in cardiomyocytes. Here, we identify key residues on the surface of an amphipathic alpha-helix unique to the regulatory domain of ankyrin-B that are essential for the function of ankyrin-B in cardiomyocytes. Using circular dichroism, we determined that a peptide representing the predicted helix folds as a helix in solution. Alanine-scanning mutagenesis revealed that residues 1773, 1777, 1780, 1784, and 1788 located in a patch on one surface the helix are critical for ankyrin-B function in cardiomyocytes. In a parallel set of experiments we determined that the molecular co-chaperone human DnaJ homologue 1 (Hdj1)/Hsp40 interacts with the ankyrin-B regulatory domain. Moreover, interaction of Hdj1/Hsp40 with the regulatory domain was mapped by random mutagenesis to same surface of the alpha-helix that is required for ankyrin-B function. These results provide new insight into the molecular basis for specificity between ankyrin-based pathways by defining a key alpha-helix structure in the divergent regulatory domain of ankyrin-B as well as interaction of the helix with Hdj1/Hsp40, the first downstream target for ankyrin-B-specific function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075330     DOI: 10.1074/jbc.M401296200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins.

Authors:  Michael J Ackerman; Peter J Mohler
Journal:  Circ Res       Date:  2010-08-20       Impact factor: 17.367

2.  Structurally similar but functionally diverse ZU5 domains in human erythrocyte ankyrin.

Authors:  Mai Yasunaga; Jonathan J Ipsaro; Alfonso Mondragón
Journal:  J Mol Biol       Date:  2012-01-30       Impact factor: 5.469

3.  Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease.

Authors:  Shane R Cunha; Solena Le Scouarnec; Jean-Jacques Schott; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2008-08-27       Impact factor: 5.000

4.  Cardiac spectrins: alternative splicing encodes functional diversity.

Authors:  Thomas J Hund; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2010-02-06       Impact factor: 5.000

5.  Ankyrin-B regulates Kir6.2 membrane expression and function in heart.

Authors:  Jingdong Li; Crystal F Kline; Thomas J Hund; Mark E Anderson; Peter J Mohler
Journal:  J Biol Chem       Date:  2010-07-07       Impact factor: 5.157

Review 6.  Coordinating electrical activity of the heart: ankyrin polypeptides in human cardiac disease.

Authors:  Jerry Curran; Peter J Mohler
Journal:  Expert Opin Ther Targets       Date:  2011-04-04       Impact factor: 6.902

7.  Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic β cell insufficiency.

Authors:  Damaris N Lorenzo; Jane A Healy; Janell Hostettler; Jonathan Davis; Jiayu Yang; Chao Wang; Hans Ewald Hohmeier; Mingjie Zhang; Vann Bennett
Journal:  J Clin Invest       Date:  2015-07-13       Impact factor: 14.808

8.  Ankyrin regulates KATP channel membrane trafficking and gating in excitable cells.

Authors:  Crystal F Kline; Thomas J Hund; Peter J Mohler
Journal:  Channels (Austin)       Date:  2010-01-16       Impact factor: 2.581

9.  Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.

Authors:  Shane R Cunha; Peter J Mohler
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

Review 10.  Cardiac ankyrins in health and disease.

Authors:  Seyed M Hashemi; Thomas J Hund; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2009-04-24       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.